The value of BNP testing

Archives of Internal Medicine

Volumn 166, Issue 10, 2006, Pages 1063-1064

  Hlatky, Mark ^a   Heidenreich, Paul ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DYSPNEA; EDITORIAL; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE WALL; HUMAN; PATIENT CARE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SCREENING TEST;

BIOLOGICAL MARKERS; DYSPNEA; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 33646784620     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.10.1063     Document Type: Editorial

References (5)

1. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316-322.
2. Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? J Am Coll Cardiol. 2004;44:740-749.
3. Wright SP, Doughty RN, Pearl A, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol. 2003;42:1793-1800.
4. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654.
5. Mueller C, Laule-Kilian K, Schindler C, et al. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med. 2006;166:1081-1087.